Skip to content
Biodatica
Start free

PhytoHealth Corporation

Taipei

OncologyPhase II
Sign in to watch

What changed

NIH R01 · $0.6M · Targeting SEC61 complex to overcome resistance to immunotherapy in GBM

5mo agoGrant renewalFeb 10, 2026Source filing (opens the source filing in a new tab)

Momentum

88no change

Momentum 88 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase II

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    NA registered

    Jan 19, 2026

    Targeted Temperature Management, Nursing Education, Serious Game, Cardiac Arrest · RECRUITING · sponsor: National Taiwan University Clinical Trial Center · Serious Game for Improving Targeted Temperature Management Knowledge and Situational Awareness in Critical Care Nurses

    ClinicalTrials.gov · NCT07239206 (opens the source filing in a new tab)

  2. Trial

    Study registered

    Jul 1, 2025

    ALK-positive Advanced NSCLC Patients, Primary Resistance, NGS · NOT_YET_RECRUITING · sponsor: National Taiwan University Hospital · Primary Resistance Mechanisms of ALK TKIs

    ClinicalTrials.gov · NCT07045610 (opens the source filing in a new tab)

  3. Trial

    Study registered

    May 26, 2025

    The Cardiac Function · NOT_YET_RECRUITING · sponsor: National Taiwan University Hospital · Postoperative Arrhythmia and Preoperative Cardiac Function

    ClinicalTrials.gov · NCT06999681 (opens the source filing in a new tab)

  4. Trial

    PHASE2 registered

    Jan 23, 2025

    Alopecia Areata · NOT_YET_RECRUITING · sponsor: National Taiwan University Hospital · Evaluating the Effectiveness and Tolerance of Baricitinib in the Treatment of Acute Alopecia Areata With Active Hair Shedding: A Prospective Open-Label Study

    ClinicalTrials.gov · NCT06797310 (opens the source filing in a new tab)

  5. Grant

    R01 · $578k · non-dilutive

    Jan 1, 2025

    NORTHWESTERN UNIVERSITY · PI BALYASNIKOVA, IRINA V · NCI · award ends Dec 31, 2029 · Targeting SEC61 complex to overcome resistance to immunotherapy in GBM

    NIH RePORTER · NIH RePORTER 11251808 (opens the source filing in a new tab)

  6. Grant

    R01 · $666k · non-dilutive

    Dec 1, 2024

    NORTHWESTERN UNIVERSITY · PI BALYASNIKOVA, IRINA V · NCI · award ends Nov 30, 2028 · Spatial and Temporal Tracking of Neural Stem Cells Migration to Brain Metastases of Breast Cancer using High Resolution Imaging

    NIH RePORTER · NIH RePORTER 11238077 (opens the source filing in a new tab)

  7. Trial

    NA registered

    Feb 21, 2023

    Gastric Cancer, Immunonutrition, Gastrostomy · RECRUITING · sponsor: National Taiwan University Hospital · Oral Supplementation of Glutamine on Gastric Cancer Patients After Gastrectomy

    ClinicalTrials.gov · NCT06027242 (opens the source filing in a new tab)

  8. Trial

    Study registered

    Jan 1, 2016

    Pancreatic Neoplasm · RECRUITING · sponsor: National Taiwan University Hospital · Endocrine-exocrine Functions and Prognosis After Pancreatectomy

    ClinicalTrials.gov · NCT07396662 (opens the source filing in a new tab)

  9. Trial

    PHASE2 registered

    Feb 1, 2014

    Cancer, Surgery, Fatigue · WITHDRAWN · sponsor: PhytoHealth Corporation · Study of PG2 Injection for Improving Fatigue in Patients After Palliative Abdominal Surgery for Cancer

    ClinicalTrials.gov · NCT02077621 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources